PHARMACOTHERAPEUTICAL PROFILE OF DIABETIC PATIENTS TREATED IN PUBLIC HEALTH SÃO LUIS GONZAGA - RS
DOI:
https://doi.org/10.14450/2318-9312.v25.e3.a2013.pp132-137Keywords:
Diabetes Mellitus, pharmacotherapeutical profile, Pharmaceutical CareAbstract
Diabetes mellitus is a multiple etiology syndrome resulting from partial or total lack of insulin. The long-term consequences may be serious complications, including vision problems, limb amputations, with possible progression to renal failure and other diseases. The study focus was to evaluate the pharmacotherapeutical profile of type 2 diabetic patients from Duque de Caxias district in the city of São Luiz Gonzaga/RS. A cross-section observational prospective study was conducted. The variables studied were: gender, age, time of diagnosis, knowledge about the clinical symptoms, dosage blood glucose monitoring and used medications. We interviewed twenty-five patients of whom 56% were male (14/25). The mean age of respondents was 60.2 years old and the diagnosis time in most patients is less than ten years 84%. The most common symptoms were fatigue and dizziness in 20% patients (5/25), somnolence and feet numbness were cited by 16% patients (4/25). Regarding blood glucose levels presented fasting, 32% patients (8/25) showed 100-140 mg/dL, 36% patients (9/25) 140-200 mg/dL, 24% (6/25) 200-400 mg/dL and 8% (2/25) above 400 mg/dL. The medications most commonly used were metformin 36% (9/25), followed by glibenclamide 24% (6/25), although 40% (10/25) said to be in use of both drugs. Diabetes Mellitus presented himself as a disease little known to the own patients, thus education programs and guideline for diabetic patients are essential.Downloads
Published
2013-09-30
How to Cite
BORRÉ, T., & OLIVEIRA, T. B. de. (2013). PHARMACOTHERAPEUTICAL PROFILE OF DIABETIC PATIENTS TREATED IN PUBLIC HEALTH SÃO LUIS GONZAGA - RS. Infarma - Pharmaceutical Sciences, 25(3), 132–137. https://doi.org/10.14450/2318-9312.v25.e3.a2013.pp132-137
Issue
Section
Original article
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).